What Epithalon actually is

Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide modeled on the pineal regulator Epithalamin. Khavinson and colleagues at the St. Petersburg Institute of Bioregulation reported telomerase reactivation in cultured human somatic cells,¹ restoration of nocturnal melatonin amplitude in aged animals,² and biomarker shifts tracking chronological age.

Unlike growth hormone secretagogues, Epithalon does not engage the somatotropic axis. It modulates pineal output and influences gene programs related to circadian regulation, antioxidant defense, and cellular replicative capacity — used at Luxbae as a longevity-frame compound rather than a body-composition tool.

At Luxbae, Epithalon is prescribed and supervised by Dr. Ernst von Schwarz, MD, PhD after a complimentary medical consultation.

Mechanism — Pineal signaling, telomere maintenance

Re-tunes melatonin pulse, supports telomerase pathways in somatic lines, modulates SOD and catalase expression in aged animal models.³

What the research shows

Telomerase activity. Khavinson reported telomerase reactivation and telomere elongation in cultured human somatic cells.¹

Melatonin rhythm. Restoration of nocturnal melatonin amplitude in aged-rat models.²

Antioxidant gene expression. Upregulation of SOD and catalase suggests indirect oxidative-stress protection.³

Side effects: Mild injection-site reactions, transient drowsiness, or vivid dreams during loading.

FDA note: Not FDA-approved; prescribed as pharmacy-compounded protocol under medical supervision.

Epithalon FAQ

Does Epithalon make me feel different right away?
Most patients notice no immediate subjective effect. Changes are sleep quality, recovery, and skin texture over weeks.

Why a cycle rather than continuous use?
Protocols administer Epithalon as discrete pulses, mimicking the pineal rhythm.

References

1. Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592.
2. Anisimov VN, Khavinson VK. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149.
3. Khavinson VK, Lin’kova NS, Tarnovskaya SI. Short peptides regulate gene expression. Bull Exp Biol Med. 2016;162(2):288-292.